Based on existing surgical procedure utilization and our estimated utilization of skin substitute products in the ASC setting, our estimated separate payments for skin substitutes in the ASC setting did not impact the ASC weight scalar
Kuwabara S, Nakazawa R, Azuma N, Suzuki M, Miyajima K, Fukutake T, Hattori T
Patients often experience nausea during the first few weeks of treatment
The extra peptide mass gives you room to choose concentrations that make dosing cleaner without running out too quickly
TB-500 has a substantially longer plasma half-life, approximately two to three hours after subcutaneous or intramuscular administration in rats, followed by tissue redistribution
The compound appears to have linear kinetic behavior in mouse plasma with a half-life of 5.7 h